‘Game-changer’ cancer treatment is focus of Gilead’s $12 billion cell therapy deal – San Francisco Chronicle
San Francisco Chronicle |
'Game-changer' cancer treatment is focus of Gilead's $12 billion cell therapy deal
San Francisco Chronicle The deal with Santa Monica's Kite is expected to close later this year and will intensify competition among major drug companies to introduce a cutting-edge cancer treatment known as CAR T cell therapy. The therapy extracts a patient's own cells from … New drug price questions loom after Gilead's cancer purchase Gilead's $11.9 billion purchase of a groundbreaking cancer therapy could drag it into a new debate on prices Analysts Mixed On Gilead-Kite, But One Key Rival Stands To Benefit |
